Epidemiology and Health

Erratum

Characteristics of imported and domestic malaria cases in Gyeonggi Province, Korea: Sunghee Hong, Jihye Kim, Soo-Nam Jo, Jong-Hun Kim, Boyoung Park, Bo Youl Choi; Epidemiol Health. 2025;47:e2024087.E. Published online March 17, 2025; DOI: https://doi.org/10.4178/epih.e2024087.E; Corrects: Epidemiol Health 2024;46:e2024087

1,170 View
90 Download

PDF: Abstract; Summary

Original Article

Prevalence and trends of cigarette smoking among adults with HIV infection compared with the general population in Korea: Boyoung Park, Yoonyoung Jang, Taehwa Kim, Yunsu Choi, Kyoung Hwan Ahn, Jung Ho Kim, Hye Seong, Jun Yong Choi, Hyo Youl Kim, Joon Young Song, Shin-Woo Kim, Hee Jung Choi, Dae Won Park, Young Kyung Yoon, Sang Il Kim; Epidemiol Health. 2024;46:e2024097. Published online December 16, 2024; DOI: https://doi.org/10.4178/epih.e2024097

2,583 View
174 Download

Abstract Summary PDF: Abstract
OBJECTIVES
This study compared the current smoking prevalence among adults with human immunodeficiency virus (HIV) infection to that of the general Korean population and analyzed changes in smoking prevalence and cessation rates from 2009 to 2020.
METHODS
The study included a total of 10,980 adults with HIV infection who underwent a health screening examination (National Health Insurance Service-National Health Information Database; NHIS-NHID), 1,230 individuals with HIV infection who participated in the Korea HIV/AIDS Cohort (KoCosHIV), and 76,783 participants from the Korea National Health and Nutrition Examination Survey (KNHANES). We estimated the current smoking prevalence and the quit ratio, defined as the ratio of former smokers to ever-smokers.
RESULTS
In the NHIS-NHID and KoCosHIV studies, the prevalence of current and former smoking among adults with HIV was 44.2% (95% confidence interval [CI], 43.2 to 45.1) and 15.6% (95% CI, 14.9 to 16.3), and 47.7% (95% CI, 43.7 to 51.8) and 16.9% (95% CI, 11.8 to 22.0), respectively. In the KNHANES, these rates were 22.5% and 18.1%, respectively. The standardized prevalence ratio of current smoking among adults with HIV was 1.76 in the NHIS-NHID and 1.97 in the KoCosHIV. Furthermore, the likelihood of quitting smoking was lower among adults with HIV than in the general population (NHIS-NHID: 26.1%; 95% CI, 25.0 to 27.1; KoCosHIV: 26.2%; 95% CI, 20.2 to 32.1; KNHANES: 44.6%; 95% CI, 44.5 to 44.6). Among HIV-positive adults, there was a 1.53% decline in the current smoking rate and a 2.86% increase in the quit ratio.
CONCLUSIONS
Adults with HIV were more likely to smoke and less likely to quit smoking than the general adult population. Tobacco screening and cessation strategies should specifically target this population.; Summary

Korean summary
HIV 감염자에서 일반인구와 비교한 현재흡연의 표준화 유병비는 1.76-1.97이었음 HIV 감염자의 현재 흡연율은 연평균 1.53% 감소하고, 흡연자의 금연율은 연평균 2.86% 증가함 HIV 감염자들은 일반인구와 비교해서 흡연율이 높고,흡연자의 금연율은 낮음

Key Message
The standardized prevalence ratio of current smoking among adults with HIV compared with general population was 1.76 ~ 1.97. Among HIV-positive adults, there was a 1.53% decline in the current smoking rate and a 2.86% increase in the quit ratio. Adults with HIV were more likely to smoke and less likely to quit smoking than the general adult population.

Cohort Profile

Cohort study profile: a cohort of Korean atomic bomb survivors and their offspring: Hamin Lee, Jin-Wu Nam, Mi Kyung Kim, Inah Kim, Yu-Mi Kim, Boyoung Park; Epidemiol Health. 2024;46:e2024089. Published online November 18, 2024; DOI: https://doi.org/10.4178/epih.e2024089

1,944 View
58 Download
1 Web of Science
1 Crossref

Abstract Summary PDF

Abstract

The Korean Atomic Bomb Survivor Cohort (K-ABC) study was designed to investigate the health impacts of atomic bomb exposure on Korean survivors and to explore whether these effects are passed down genetically to their descendants. This paper outlines the study’s design, data collection methods, baseline socio-demographic characteristics, exposure status, and disease prevalence among the participants, based on survey responses and health examinations. From 2020 to 2024, a total of 2,544 individuals, comprising 1,109 atomic bomb survivors (G1), 1,193 children of G1 (G2), and 242 grandchildren of G1 (G3), consented to participate in the study. Of these, 1,828 participants (659 in G1, 927 in G2, and 242 in G3) completed the survey and underwent health examinations, representing a participation rate of 71.9%. Exposure information was gathered using a questionnaire and verified through records from the Korean Red Cross and a handbook issued by the Japanese government. Disease prevalence was determined based on participants’ self-reported physician diagnoses. This study presents details about the K-ABC study and provides baseline data on the participants recruited. These data will be valuable for interpreting the results of future K-ABC studies.

Summary

Korean summary
한국인 원폭피해자 코호트 연구는 1945년 일본에서 원자폭탄에 피폭된 원폭 피해자 1세와 이들의 자녀인 2세, 3세의 건강과 질병 위험도을 장기적으로 조사한다. 이를 위해 2020년부터 2023년까지 설문조사를 통해 정보를 수집하였고, 이후 설문조사와 함께 건강보험공단, 국립암센터, 통계청 등 공공 기관에서 보유하고 있는 데이터를 연계하여 추적관찰을 수행해 나갈 예정이다.

Key Message
The Korean atomic bomb survivor’s cohort study investigates the long-term health and disease risks of first generation atomic bomb survivors exposed in Japan in 1945, as well as their second generation and third generations. From 2020 to 2023, information was collected through surveys. Follow-up will be conducted through surveys and secondary data linkage from public institutions such as the National Health Insurance Service, the Korea Central Cancer Registry, and Statistics Korea.

Citations

Citations to this article as recorded by

Validation of self-reported cancer diagnoses in the Korean Atomic Bomb Survivor Cohort study
Hamin Lee, Jin-Wu Nam, Mi Kyung Kim, Inah Kim, Yu-Mi Kim, Boyoung Park
Cancer Epidemiology.2025; 97: 102817. CrossRef

Original Article

Characteristics of imported and domestic malaria cases in Gyeonggi Province, Korea: Sunghee Hong, Jihye Kim, Soo-Nam Jo, Jong-Hun Kim, Boyoung Park, Bo Youl choi; Epidemiol Health. 2024;46:e2024087. Published online November 8, 2024; DOI: https://doi.org/10.4178/epih.e2024087; Correction in: Epidemiol Health 2025;47(0):e2024087.E

2,534 View
137 Download

Abstract Summary PDF: Abstract
OBJECTIVES
This study explored 11 years of malaria data from mandatory reporting in Gyeonggi Province, Korea, to provide information for prevention strategies by linkage to nationwide health claims data.
METHODS
Reported malaria cases in Gyeonggi Province from 2011 to 2021 were linked to medical usage data from the National Health Insurance Database. Data about hospitalization, antibiotic prescription and duration, malarial species, and sociodemographic information of the cases were included.
RESULTS
Between 2011 and 2021, a total of 3,011 malaria cases were reported, consisting of 2,828 domestic (93.9%) and 183 imported (6.1%) cases. Over 80% of the cases involved males, with the majority of patients being in their 20s. Both domestic and imported cases peaked between June and August over the years. Imported cases had a higher hospitalization rate (66.9%) compared to domestically-acquired cases (54.9%). There was a significant variation in treatment rates, with 80.7% of imported cases and 74.6% of domestic cases receiving treatment. For domestic cases, chloroquine combined with primaquine was the most commonly prescribed treatment (77.0%), while atovaquone-proguanil was frequently used for imported cases (25.9%). Plasmodium vivax was the predominant species in domestic cases (94.9%), whereas P. malariae was more common in imported cases (62.3%). The overall number of reported malaria cases declined following a sharp decrease in imported cases in 2020 and 2021.
CONCLUSIONS
Despite a decreasing trend in malaria cases reported in Gyeonggi Province, imported cases exhibited higher hospitalization rates and different antibiotic prescription and treatment patterns, reflecting the presence of a different malarial species.; Summary

Korean summary
- 2011년부터 2021년까지 경기도에서 보고된 말라리아 사례 중 94%는 국내 발생이었으며, 80% 이상이 남성이었습니다. - 국내 발생은 20대에서 가장 많았으며, Plasmodium vivax가 주요 원인균으로 확인되었습니다. - 해외 유입 사례는 Plasmodium malariae가 지배적이며, 더 높은 입원율과 치료율을 보였습니다.

Key Message
- Between 2011 and 2021, 94% of malaria cases reported in Gyeonggi Province were domestically acquired, with over 80% of cases involving male patients. - Domestic cases were most common among individuals in their 20s, with Plasmodium vivax being the dominant species. - Imported cases primarily involved Plasmodium malariae, which showed higher hospitalization and treatment rates.

Methods

Validation of self-reported morbidities in the Korean Atomic Bomb Survivor Cohort: Ansun Jeong, Somin Jeon, Seong-geun Moon, Mi Kyung Kim, Inah Kim, Yu-Mi Kim, Boyoung Park; Epidemiol Health. 2024;46:e2024058. Published online June 28, 2024; DOI: https://doi.org/10.4178/epih.e2024058

2,367 View
53 Download
1 Crossref

Abstract Summary PDF Supplementary Material

Abstract

OBJECTIVES
This study aimed to evaluate the agreement of disease status collected through a survey of the Korean Atomic Bomb Survivor Cohort (K-ABC), compared with medical claim records from the Korean National Health Insurance Service (NHIS) database and the Korean Central Cancer Registry (KCCR).

METHODS

Data on the lifetime physician-diagnosed morbidities of 1,215 K-ABC participants were collected through an interviewer-administered questionnaire between 2020 and 2022. Survey data were linked to the NHIS and KCCR databases. Eleven diseases were included for validation. We evaluated the following indicators: sensitivity, specificity, positive predictive value, negative predictive value, accuracy, the area under the curve, and the kappa coefficient.

RESULTS

The mean±standard deviation age was 62.1±18.7 years, and 42.6% of the participants were aged ≥70 years. Hypertension and cataracts showed the highest prevalence rates (33.8 and 28.8%, respectively). Hypertension, diabetes, and cancer demonstrated high sensitivity (>0.8) and specificity (>0.9), whereas diabetes, cancer, myocardial infarction, angina pectoris, and asthma exhibited high accuracy (>0.9). In contrast, arthritis, allergic rhinitis, and asthma showed low sensitivity (<0.4) and kappa values (<0.3). In the participants aged ≥70 years, the kappa value was ≥0.4 for all diseases except arthritis, allergic rhinitis, and asthma.

CONCLUSIONS

The results from this initial analysis showed relatively high agreement between the survey and NHIS/KCCR databases, especially for hypertension, diabetes, and cancer. Our findings suggest that the information on morbidities collected through the questionnaires in this cohort was valid for both younger and older individuals.

Summary

Korean summary
한국인 원폭피해자 코호트에서 설문으로 조사한 질병 과거력과 국민건강보험공단/암등록자료와의 일치도는 높은 편이었으며, 특히 고혈압, 당뇨, 암에서 높았다. 설문으로 조사한 질병 과거력은 젊은 대상자와 고령 대상자 모두에서 높았다.

Key Message
High agreement between the survey and NHIS/KCCR databases, especially for hypertension, diabetes, and cancer in the Korean Atomic Bomb Survivor Cohort was observed. The information on morbidities collected through the questionnaires in this cohort was valid for both younger and older individuals.

Citations

Citations to this article as recorded by

Validation of self-reported cancer diagnoses in the Korean Atomic Bomb Survivor Cohort study
Hamin Lee, Jin-Wu Nam, Mi Kyung Kim, Inah Kim, Yu-Mi Kim, Boyoung Park
Cancer Epidemiology.2025; 97: 102817. CrossRef

Original Articles

Increased risk of cancer and cancer-related mortality in middle-aged Korean women with prediabetes and diabetes: a population-based study: Thi Xuan Mai Tran, Soyeoun Kim, Huiyeon Song, Boyoung Park; Epidemiol Health. 2023;45:e2023080. Published online August 28, 2023; DOI: https://doi.org/10.4178/epih.e2023080

5,504 View
82 Download
1 Web of Science
1 Crossref

Abstract Summary PDF Supplementary Material

Abstract

OBJECTIVES
This study investigated the risk of developing and dying from all types of cancer, as well as cancer-specific mortality, in women diagnosed with prediabetes and diabetes.

METHODS

We included women aged ≥40 years who underwent cancer screening from 2009 to 2014 with follow-up until 2020. Diabetes status was determined based on fasting plasma glucose levels, self-reported history of diabetes, and the use of antidiabetic medication. We quantified the risk of cancer and mortality in the prediabetes and diabetes groups, relative to the normoglycemia group, by calculating adjusted hazard ratios (aHRs).

RESULTS

The study included 8,309,393 participants with a mean age of 52.7±9.7 years. Among these participants, 522,894 cases of cancer and 193,283 deaths were detected. An increased risk of cancer was observed in both the prediabetes group (aHR, 1.03; 95% confidence interval [CI], 1.02 to 1.04) and the diabetes group (aHR, 1.13; 95% CI, 1.12 to 1.14). The highest risk was identified in those with diabetes who developed liver (aHR, 1.72; 95% CI, 1.66 to 1.79), pancreatic (aHR, 1.68; 95% CI, 1.60 to 1.76), and gallbladder cancer (aHR, 1.43; 95% CI, 1.36 to 1.51). Women with prediabetes and diabetes exhibited a 1.07-fold (95% CI, 1.05 to 1.08) and 1.38-fold (95% CI, 1.36 to 1.41) increased risk of death from cancer, respectively.

CONCLUSIONS

Both prediabetes and diabetes were associated with an elevated risk of cancer, as well as an increased risk of death from cancer, in middle-aged Korean women. However, the degree of risk varied depending on the specific site of the cancer.

Summary

Korean summary
40세 이상의 중년 여성에서 당뇨 또는 당뇨 전 단계는 암 발생 위험과 암으로 인한 사망위험을 증가시킴. 암 종별로는 위암, 대장암, 직장암, 간암, 담낭암, 췌장암, 유방암, 자궁경부암, 자궁암, 신장암, 방광암의 발생 위험이 증가한 반면, 갑상선암의 발생 위험은 감소하였음. 거의 대부분의 암종에서 당뇨는 암으로 인한 사망위험을 증가시킴

Key Message
Both prediabetes and diabetes were independently associated with an overall increased risk of cancer, with a stronger association with malignancies in the liver and pancreas in women. Additionally, both prediabetes and diabetes status are associated with an elevated risk of death from cancer. These findings support the need for prevention and management to reduce cancer-related burden and premature deaths due to cancer, not only in individuals with diabetes but also in those with prediabetes.

Citations

Citations to this article as recorded by

Prediabetes persistence or remission and subsequent risk of gallbladder cancer: A nationwide cohort study
Joo-Hyun Park, Jung Yong Hong, Kyungdo Han, Young Suk Park, Joon Oh Park, Ho Yeong Lim, Jay J. Shen
European Journal of Cancer.2024; 213: 114312. CrossRef

Changes in metabolic syndrome and the risk of breast and endometrial cancer according to menopause in Korean women: Thi Xuan Mai Tran, Soyeoun Kim, Boyoung Park; Epidemiol Health. 2023;45:e2023049. Published online May 1, 2023; DOI: https://doi.org/10.4178/epih.e2023049

9,704 View
166 Download
4 Web of Science
5 Crossref

Abstract Summary PDF Supplementary Material

Abstract

OBJECTIVES
This study investigated how changes in metabolic syndrome (MetS) are associated with the subsequent risk of breast and endometrial cancer according to menopausal status.

METHODS

This cohort study, using data from the National Health Insurance Service database, included women aged ≥40 years who underwent 2 biennial cancer screenings (2009-2010 and 2011-2012) and were followed up until 2020. Participants were grouped into MetS-free, MetS-recovery, MetS-development, and MetS-persistent groups. Menopausal status (premenopausal, perimenopausal, and postmenopausal) was assessed at 2 screenings. Cox proportional hazard regression was used to assess the association between MetS changes and cancer risk.

RESULTS

In 3,031,980 women, breast and endometrial cancers were detected in 39,184 and 4,298, respectively. Compared with the MetS-free group, those who recovered, developed, or had persistent MetS showed an increased risk of breast cancer, with adjusted hazard ratios (aHRs) of 1.05, 1.05, and 1.11, respectively (p<0.005). MetS persistence was associated with an increased risk of breast cancer in postmenopausal women (aHR, 1.12, 95% confidence interval [CI], 1.08 to 1.16) but not in premenopausal or perimenopausal women. MetS persistence was associated with an increased risk of endometrial cancer in premenopausal, perimenopausal, and postmenopausal women, with aHRs of 1.41 (95% CI, 1.17 to 1.70), 1.59 (95% CI, 1.19 to 2.12), and 1.47 (95% CI, 1.32 to 1.63), respectively.

CONCLUSIONS

Increased breast cancer risk was associated with recovered, developed, and persistent MetS in postmenopausal women. Meanwhile, increased endometrial cancer risk was found in obese women who recovered from MetS or persistently had MetS, regardless of menopausal status, when compared to MetS-free women.

Summary

Korean summary
- 폐경후 여성에서 대사증후군이 회복되었거나, 지속적으로 대사증후군을 앓고 있거나, 대사증후군이 발병한 여성은 유방암 위험과 관련이 있었습니다. - 한편, 폐경 상태와 관계없이 대사증후군에서 회복되었거나 지속적으로 대사증후군를 앓고 있는 비만 여성은 대사증후군이 없는 여성에 비해 자궁내막암 위험이 증가하는 것으로 나타났습니다.

Key Message
- Increased breast cancer risk was associated with recovered, developed, and persistent MetS in postmenopausal women. - Increased endometrial cancer risk was found in obese women who recovered from MetS or persistently had MetS, regardless of menopausal status, when compared to MetS-free women.

Citations

Citations to this article as recorded by

Distribution and Related Influencing Factors of AMH Level in Family-Planning Women of Childbearing Age: A Cross-Sectional Study from Beijing, China
Jinwei Song, Songkun Gao, Lixia Zhao, Xiaolong Tong
International Journal of Women's Health.2025; Volume 17: 99. CrossRef
Metabolic Syndrome and Survival Outcomes in Endometrial Cancer
Alina-Gabriela Marin, Alexandru Filipescu, Radu Vladareanu, Aida Petca
Cureus.2024;[Epub] CrossRef
Is Insulin Resistance a High-Risk Factor for Postmenopausal Endometrial Cancer: Insights from the Triglyceride Glucose (TyG) Index and the Metabolic Score for Insulin Resistance (METS-IR)
Songkun Gao, Jinhua Wang, Tong Wang, Jiandong Wang
International Journal of Women's Health.2024; Volume 16: 2355. CrossRef
Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses
George Anderson
Exploration of Targeted Anti-tumor Therapy.2023; : 962. CrossRef
Changed Endocrinology in Postmenopausal Women: A Comprehensive View
Vidhi Motlani, Gunjan Motlani, Soumya Pamnani, Akshat Sahu, Neema Acharya
Cureus.2023;[Epub] CrossRef

Erratum

Erratum: Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States: Soyeoun Kim, Jinhyun Kim, Bo Youl Choi, Boyoung Park; Epidemiol Health. 2022;44:e2022011.E. Published online December 31, 2022; DOI: https://doi.org/10.4178/epih.e2022011.E; Corrects: Epidemiol Health 2022;44:e2022011

6,291 View
161 Download
2 Crossref

PDF

Abstract

Summary

Citations

Citations to this article as recorded by

Impact of COVID-19-related nonpharmaceutical interventions on diarrheal diseases and zoonotic Salmonella
Linlin Huang, Haiyang Zhou, Jiaqi Chen, Chenghao Jia, Abubakar Siddique, Beibei Wu, Haoqiu Wang, Biao Tang, Fang He, Guoping Zhao, Min Yue
hLife.2024; 2(5): 246. CrossRef
Impact of the COVID‐19 pandemic on the circulation of other pathogens in England
Lauren J. Hayes, Hannah Uri, Denisa Bojkova, Jindrich Cinatl, Mark N. Wass, Martin Michaelis
Journal of Medical Virology.2023;[Epub] CrossRef

COVID-19: Brief Communication

Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States: Soyeoun Kim, Jinhyun Kim, Bo Youl Choi, Boyoung Park; Epidemiol Health. 2022;44:e2022011. Published online January 3, 2022; DOI: https://doi.org/10.4178/epih.e2022011; Correction in: Epidemiol Health 2022;44(0):e2022011.E

15,626 View
501 Download
7 Web of Science
7 Crossref

Abstract Summary PDF

Abstract

OBJECTIVES
This study examined how trends in the weekly frequencies of gastrointestinal infectious diseases changed before and during the coronavirus disease 2019 (COVID-19) pandemic in Korea, and compared them with the trends in the United States.

METHODS

We compared the weekly frequencies of gastrointestinal infectious diseases (16 bacterial and 6 viral diseases) in Korea during weeks 5-52 before and after COVID-19. In addition, the weekly frequencies of 5 gastrointestinal infectious diseases in the United States (data from the Centers for Disease Control and Prevention) that overlapped with those in Korea were compared.

RESULTS

The mean weekly number of total cases of gastrointestinal infectious diseases in Korea showed a significant decrease (from 522 before COVID-19 to 245 after COVID-19, p<0.01). Only bacterial gastrointestinal infectious diseases caused by Campylobacter increased significantly; other bacterial gastrointestinal infectious diseases showed either a decrease or no change. The incidence of all other viral diseases decreased. In the United States, the weekly numbers of Salmonella, Campylobacter, typhoid, shigellosis, and hepatitis A virus cases sharply decreased after the COVID-19 outbreak. The weekly case numbers of all viral diseases markedly decreased in both countries; however, bacterial gastrointestinal infectious diseases showed a different pattern.

CONCLUSIONS

The incidence of gastrointestinal infectious diseases decreased after the COVID-19 outbreak. In contrast, Campylobacter infections showed an increasing trend in Korea, but a decreasing trend in the United States. Further studies are needed to elucidate the different trends in bacterial and viral infectious diseases before and after non-pharmaceutical interventions and between different countries.

Summary

Korean summary
한국과 미국 모두 코로나-19 발생 이후 위장관 감염 질환의 발생은 감소하고 있습니다. 하지만, 미국과 달리 한국에서는 캄필로박터 감염은 증가 하고 있습니다. 이는 COVID-19이 발생한 이후 캄필로박터 감염의 열악한 통제의 가능성을 설명할 수 있습니다.

Key Message
The incidence of gastrointestinal infectious diseases decreased after the COVID-19 outbreak, however, campylobacter infections showed an increasing trend in Korea, unlike the United States, which could explain the poor control of Campylobacter.

Citations

Citations to this article as recorded by

Trends for Syndromic Surveillance of Norovirus in Emergency Department Data Based on Chief Complaints
Soyeoun Kim, Sohee Kim, Bo Youl Choi, Boyoung Park
The Journal of Infectious Diseases.2024; 230(1): 103. CrossRef
Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea
Taehee Chang, Sung-il Cho, Dae sung Yoo, Kyung-Duk Min
Emerging Infectious Diseases.2024;[Epub] CrossRef
Impact of non-pharmaceutical interventions during the COVID-19 pandemic on pathogens transmitted via food in the Netherlands
Roan Pijnacker, Lapo Mughini-Gras, Linda Verhoef, Maaike van den Beld, Eelco Franz, Ingrid Friesema
Epidemiology and Infection.2024;[Epub] CrossRef
Impact of the COVID‐19 pandemic on the circulation of other pathogens in England
Lauren J. Hayes, Hannah Uri, Denisa Bojkova, Jindrich Cinatl, Mark N. Wass, Martin Michaelis
Journal of Medical Virology.2023;[Epub] CrossRef
Understanding the impact of the COVID-19 pandemic response on GI infection surveillance trends in England, January 2020–April 2022
Nicola K. Love, Amy Douglas, Saheer Gharbia, Helen Hughes, Roger Morbey, Isabel Oliver, Gillian E. Smith, Alex J. Elliot
Epidemiology and Infection.2023;[Epub] CrossRef
Trends in Gastrointestinal Infections during the COVID-19 Pandemic and Concerns of Post-Pandemic Resurgence in Japan
Takuma Higurashi, Shigeki Tamura, Noboru Misawa, Nobuyuki Horita
Diseases.2023; 12(1): 4. CrossRef
Characteristics and related factors of waterborne and foodborne infectious disease outbreaks before and after the onset of the COVID-19 pandemic (2017–2021) in the Republic of Korea: a descriptive study
Eunkyoung Kim, Bryan Inho Kim
Osong Public Health and Research Perspectives.2023; 14(6): 483. CrossRef

COVID-19: Brief Communication

Time-variant reproductive number of COVID-19 in Seoul, Korea: Seong-Geun Moon, Yeon-Kyung Kim, Woo-Sik Son, Jong-Hoon Kim, Jungsoon Choi, Baeg-Ju Na, Boyoung Park, Bo Youl Choi; Epidemiol Health. 2020;42:e2020047. Published online June 28, 2020; DOI: https://doi.org/10.4178/epih.e2020047

17,065 View
349 Download
2 Web of Science
4 Crossref

Abstract Summary PDF Supplementary Material

Abstract

OBJECTIVES
To estimate time-variant reproductive number (Rt) of coronavirus disease 19 based on either number of daily confirmed cases or their onset date to monitor effectiveness of quarantine policies.

METHODS

Using number of daily confirmed cases from January 23, 2020 to March 22, 2020 and their symptom onset date from the official website of the Seoul Metropolitan Government and the district office, we calculated Rt using program R’s package “EpiEstim”. For asymptomatic cases, their symptom onset date was considered as -2, -1, 0, +1, and +2 days of confirmed date.

RESULTS

Based on the information of 313 confirmed cases, the epidemic curve was shaped like ‘propagated epidemic curve’. The daily Rt based on Rt_c peaked to 2.6 on February 20, 2020, then showed decreased trend and became <1.0 from March 3, 2020. Comparing both Rt from Rt_c and from the number of daily onset cases, we found that the pattern of changes was similar, although the variation of Rt was greater when using Rt_c. When we changed assumed onset date for asymptotic cases (-2 days to +2 days of the confirmed date), the results were comparable.

CONCLUSIONS

Rt can be estimated based on Rt_c which is available from daily report of the Korea Centers for Disease Control and Prevention. Estimation of Rt would be useful to continuously monitor the effectiveness of the quarantine policy at the city and province levels.

Summary

Korean summary
우리나라 전체와 각 시도별 일별 증상 발현자 수 또는 확진자 수를 이용하여 추정한 Rt로 방역정책의 효과를 국가 및 시도 수준에서 지속적으로 모니터링 할 필요가 있다.

Citations

Citations to this article as recorded by

Reproduction Factor Based Latent Epidemic Model Inference: A Data-Driven Approach Using COVID-19 Datasets
Sujin Ahn, Minhae Kwon
IEEE Journal of Biomedical and Health Informatics.2023; 27(3): 1259. CrossRef
코로나19 핵심 지표 산출체계 국제 비교 및 활용도 제고 방안 연구
나애 이, 연경 김, 승필 정, 우주 이, 주환 오, 승식 황
Public Health Weekly Report.2023; 16(29): 973. CrossRef
The Impacts of Compact City Characteristics on COVID-19 Spreading Force : Focused on the Seoul Metropolitan Area
Haejun Hyun, Myungje Woo
Journal of Korea Planning Association.2023; 58(7): 5. CrossRef
COVID-19 early-alert signals using human behavior alternative data
Anasse Bari, Aashish Khubchandani, Junzhang Wang, Matthias Heymann, Megan Coffee
Social Network Analysis and Mining.2021;[Epub] CrossRef

Original Articles

Socioeconomic inequalities in obesity among Korean women aged 19-79 years: the 2016 Korean Study of Women’s Health-Related Issues: Eunji Choi, Ha Na Cho, Da Hea Seo, Boyoung Park, Sohee Park, Juhee Cho, Sue Kim, Yeong-Ran Park, Kui Son Choi, Yumie Rhee; Epidemiol Health. 2019;41:e2019005. Published online February 13, 2019; DOI: https://doi.org/10.4178/epih.e2019005

20,169 View
291 Download
6 Web of Science
5 Crossref

Abstract Summary PDF

Abstract

OBJECTIVES
While the prevalence of obesity in Asian women has remained stagnant, studies of socioeconomic inequalities in obesity among Asian women are scarce. This study aimed to examine the recent prevalence of obesity in Korean women aged between 19 years and 79 years and to analyze socioeconomic inequalities in obesity.

METHODS

Data were derived from the 2016 Korean Study of Women’s Health-Related Issues. The chi-square test and logistic regression analysis were used to analyze the associations between socioeconomic factors and obesity using Asian standard body mass index (BMI) categories: low (<18.5 kg/m2 ), normal (18.5-22.9 kg/m2 ), overweight (23.0-24.9 kg/m2 ), and obese (≥25.0 kg/ m2 ). As inequality-specific indicators, the slope index of inequality (SII) and relative index of inequality (RII) were calculated, with adjustment for age and self-reported health status.

RESULTS

Korean women were classified into the following BMI categories: underweight (5.3%), normal weight (59.1%), overweight (21.2%), and obese (14.4%). The SII and RII revealed substantial inequalities in obesity in favor of more urbanized women (SII, 4.5; RII, 1.4) and against of women who were highly educated (SII, -16.7; RII, 0.3). Subgroup analysis revealed inequalities in obesity according to household income among younger women and according to urbanization among women aged 65-79 years.

CONCLUSIONS

Clear educational inequalities in obesity existed in Korean women. Reverse inequalities in urbanization were also apparent in older women. Developing strategies to address the multiple observed inequalities in obesity among Korean women may prove essential for effectively reducing the burden of this disease.

Summary

Korean summary
한국 성인 여성의 과체중 및 비만유병률은 서구여성에 비해 낮으며 2005년 이후 큰 변화 없이 약40%대로 일정하게 유지되어왔으나, 사회경제적불평등에 대한 연구는 체계적으로 이루어지지 않음. 경사불평등(Slope index of inequality)과 상대불평등(Relative index of inequality) 지표를 사용하여 비만유병률에서 발견되는 사회경제적불평등을 조사한 결과, 교육수준별 불평등이 유의하게 나타남. 19-44세의 젊은 여성층에서는 소득수준이 낮은 집단에, 65-79세의 노년기 여성층에서는 도시화된 지역에 사는 집단에 비만유병률이 치중되어있음.

Citations

Citations to this article as recorded by

Disparities in Obesity Rates among Adults: Analysis of 514 Districts in Indonesia
Dumilah Ayuningtyas, Dian Kusuma, Vilda Amir, Dwi Hapsari Tjandrarini, Pramita Andarwati
Nutrients.2022; 14(16): 3332. CrossRef
Socioeconomic Disparities in Cardiovascular Health in South Korea
Chi-Young Lee, Eun-Ok Im
Journal of Cardiovascular Nursing.2021; 36(1): 8. CrossRef
Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study
Jin-Sung Yuk, Banghyun Lee, Kidong Kim, Myoung Hwan Kim, Yong-Soo Seo, Sung Ook Hwang, Sang-Hee Yoon, Yong Beom Kim, Wen-Chi Chou
PLOS ONE.2021; 16(4): e0250723. CrossRef
Regional Differences in Dietary Total Fat and Saturated Fatty Acid Intake and Their Associations with Metabolic Diseases among Korean Adults: Using the 2016~2019 Korea National Health and Nutrition Examination Surveys
SuJin Song, Jae Eun Shim
Korean Journal of Community Nutrition.2021; 26(6): 495. CrossRef
Regional disparities in the associations of cardiometabolic risk factors and healthy dietary factors in Korean adults
Kyungho Ha, YoonJu Song, Hye-Kyeong Kim
Nutrition Research and Practice.2020; 14(5): 519. CrossRef

Physician’s awareness of lung cancer screening and its related medical radiation exposure in Korea: Seri Hong, Suyeon Kim, Mina Suh, Boyoung Park, Kui Son Choi, Jae Kwan Jun; Epidemiol Health. 2018;40:e2018002. Published online January 20, 2018; DOI: https://doi.org/10.4178/epih.e2018002

19,298 View
271 Download
4 Web of Science
3 Crossref

Abstract Summary PDF Supplementary Material

Abstract

OBJECTIVES
Through a survey on perception of lung cancer screening and accompanying medical radiation exposure in Korea, the present study was to investigate its current situations and evaluate various perception of physicians regarding it in order to propose measures for improvements.

METHODS

Medical specialists in national cancer screening institutions selected through stratified random sampling were subjected to face-to-face interview using a structured questionnaire. We investigated physicians’ perception on effectiveness of lung cancer screening depending on screening modality, selection criteria for subjects of screening, types of equipment used to screen, and perception for seriousness of adverse effects following the test. In addition, odds ratios to underestimate risk of radiation exposure from screening were calculated through logistic regression analysis.

RESULTS

Each response that chest X-ray is effective for lung cancer screening and that smoking history is not considered prior to screening recommendation accounted for more than 60% of respondents, suggesting the chance of unnecessary screening tests. Regarding adverse effects of lung cancer screening, about 85% of respondents replied that false positive, radiation exposure, and overdiagnosis could be ignored. About 70% of respondents underestimated radiation dose from lung cancer screening, and a low proportion of physicians informed patients of radiation exposure risk.

CONCLUSIONS

It was found that most physicians underestimated harms of lung cancer screening including radiation exposure and were lack of awareness regarding lung cancer screening. It should be noted that physicians need to have proper perceptions about screening recommendation and accompanying possible harms, for successful implementation of the screening program.

Summary

Korean summary
전국 100여개 국가암검진 기관을 대상으로 폐암검진 관련 설문을 수행한 결과, 효과적인 폐암검진의 수단이나 방법에 대한 이해 및 검사에 수반되는 각종 부작용에 대한 의사들의 인식이 확연히 부족한 것으로 조사되었다. 그 중에서도 특히 의료방사선 노출에 대한 낮은 인지도는, 촬영 시 피폭량에 대한 전반적인 과소평가 및 방사선 노출 위험과 관련한 환자 교육의 부재를 통해 확인할 수 있었다. 인구집단 대상 선별검사의 도입에 따른 잠재적인 위해 가능성과 그 결과에 대한 고민은 반드시 필요하며, 이와 관련된 의료제공자들의 인식 개선을 촉구하는 본 연구는 정책 도입에 앞서 선결되어야 할 과제로서 공중보건학적 측면에서 중요한 의의를 지닌다.

Citations

Citations to this article as recorded by

Assessment of radiation knowledge and awareness among radiology staff in tertiary hospitals: a study in Wuxi, China
J. Yuan, D. Liu, J. Ni
Radioprotection.2024; 59(3): 184. CrossRef
Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption
Charlotte Poon, Tim Wilsdon, Iqra Sarwar, Alexander Roediger, Megan Yuan
Frontiers in Public Health.2023;[Epub] CrossRef
Why clinicians overtest: development of a thematic framework
Justin H. Lam, Kristen Pickles, Fiona F. Stanaway, Katy J. L. Bell
BMC Health Services Research.2020;[Epub] CrossRef

Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009: Kumban Walter Chuck, Minji Hwang, Kui Son Choi, Mina Suh, Jae Kwan Jun, Boyoung Park; Epidemiol Health. 2017;39:e2017036. Published online August 10, 2017; DOI: https://doi.org/10.4178/epih.e2017036

17,792 View
270 Download
17 Web of Science
20 Crossref

Abstract Summary PDF

Abstract

OBJECTIVES
To investigate the screening rates for gastric, breast, and cervical cancer in people with diabetes compared with people without diabetes.

METHODS

Data from the Korea National Health and Nutrition Examination Survey (2007-2009) were used. Cancer-free men who were 40 years old and over and cancer-free women who were 30 years old and over were included. The lifetime screening rate and regular screening rate were compared in people with and without diabetes.

RESULTS

Fewer people with diabetes than people without diabetes had ever received cancer screening (53.5 vs. 59.5%, p<0.001 for gastric cancer; 60.5 vs. 71.5%, p<0.001 for breast cancer; and 49.1 vs. 59.6%, p<0.001 for cervical cancer). Fewer people with diabetes than people without diabetes received the recommended screenings for gastric cancer (38.9 vs. 42.9%, p<0.001), breast cancer (38.8 vs. 44.6%, p<0.001), and cervical cancer (35.1 vs. 51.2%, p<0.001). In subgroup analyses according to socioeconomic factors, the lifetime and recommended screening rates were lower in the diabetic population in most socioeconomic subgroups. In the multivariate analysis adjusted for socioeconomic factors, people with diabetes showed lower lifetime screening rates for gastric and cervical cancer (odds ratio [OR], 0.8; 95% confidence interval [CI], 0.7 to 0.9 and OR, 0.7; 95% CI, 0.6 to 0.9), and lower regular screening rates for breast and cervical cancer (OR, 0.7; 95% CI, 0.6 to 0.9 and OR, 0.7; 95% CI, 0.5 to 0.9).

CONCLUSIONS

The cancer screening rate in people with diabetes was lower than in people without diabetes. Considering the higher cancer risk in people with diabetes, efforts to increase the screening rate in this high-risk population should be implemented.

Summary

Korean summary
기존의 여러 연구에서 당뇨병이 있는 사람에서 당뇨병이 없는 경우에 비해 암 발생의 위험이 증가하는 것이 확인되었다. 본 연구에서 당뇨병이 있는 사람과 없는 사람에서 암 수검률을 비교했을 때, 당뇨병이 있는 사람의 위암, 유방암, 자궁경부암의 평생 수검률과 권고안 이행 수검률은 모두 낮았다. 당뇨병 환자가 암 발생의 고위험군임을 고려하였을 때 이들을 대상으로 암 검진 수검률을 높이려는 노력이 필요하다.

Citations

Citations to this article as recorded by

Skin autofluorescence of advanced glycation end-products, glycemic memory, and diabetes complications
Vincent Rigalleau, Yann Pucheux, Thierry Couffinhal, Frederic J Tessier, Michael Howsam, Sébastien Rubin, Catherine Helmer, Fadi Alkhami, Alice Larroumet, Laurence Blanco, Marie-Amélie Barbet-Massin, Amandine Ferriere, Kamel Mohammedi, Ninon Foussard
Diabetes & Metabolism.2025; 51(1): 101600. CrossRef
Association Between Suicidal Ideation and Cancer Screening Uptake: Results from Middle-Aged and Older Adults in Korea
Seong-Uk Baek, Jin-Ha Yoon
Cancers.2025; 17(6): 956. CrossRef
Cancer Screening Behavior among People Living with HIV: A Cross-sectional Study at an AIDS Core Hospital in Tokyo, Japan
Haruka Tsuda, Michiko Koga, Kazuhiko Ikeuchi, Makoto Saito, Eisuke Adachi, Tadashi Kikuchi, Takeya Tsutsumi, Hiroshi Yotsuyanagi
Health Evaluation and Promotion.2024; 51(4): 377. CrossRef
Exploring the Interplay of Diabetes, Deaf Patient Reported Outcomes, and Cancer Screening in Deaf and Hard of Hearing Women
Emmanuel Perrodin-Njoku, Sowmya Rao, Regina Wang, Christopher Moreland, Poorna Kushalnagar
International Journal of Women's Health.2024; Volume 16: 1235. CrossRef
Association Between Type 1 Diabetes Mellitus and Incident Gastrointestinal Cancer in Korean Population: A Nationwide Retrospective Cohort Study
Soonsu Shin, Min‐Ho Kim, Chang‐Mo Oh, Eunhee Ha, Jae‐Hong Ryoo
Diabetes/Metabolism Research and Reviews.2024;[Epub] CrossRef
Typ-2-Diabetes mellitus und gastrointestinale Krebsvorsorge
Hans Scherübl
Zeitschrift für Gastroenterologie.2023; 61(06): 683. CrossRef
Increased Breast and Colorectal Cancer Risk in Type 2 Diabetes: Awareness Among Adults With and Without Diabetes and Information Provision on Diabetes Websites
Laura Ashley, Kathryn A Robb, Daryl B O’Connor, Rebecca Platt, Mollie Price, Olivia Robinson, Elizabeth Travis, Lorraine Lipscombe, Ramzi Ajjan, Rebecca Birch
Annals of Behavioral Medicine.2023; 57(5): 386. CrossRef
Diabetes and Cancer
Jae Won Hong
The Journal of Korean Diabetes.2023; 24(1): 12. CrossRef
Diabetes mellitus and cancer
Jae Won Hong
Cardiovascular Prevention and Pharmacotherapy.2023; 5(3): 69. CrossRef
More new cancers in type 2 diabetes with diabetic foot disease: A longitudinal observational study
Fadi Alkhami, Gauthier Borderie, Ninon Foussard, Alice Larroumet, Laurence Blanco, Marie-Amélie Barbet-Massin, Amandine Ferrière, Claire Ducos, Frédéric Domenge, Kamel Mohammedi, Vincent Rigalleau
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(10): 102859. CrossRef
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach
Evelyne Liuu, Pierre-Jean Saulnier, Elise Gand, Gautier Defossez, Amélie Jamet, Stéphanie Ragot, Marc Paccalin, Samy Hadjadj
Diabetes & Metabolism.2022; 48(2): 101289. CrossRef
Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms
Ji‐Bin Li, Keng‐Jian Ke, Wei‐Li Zhang, Ling‐Yan Wang, Yan‐Ping Wu, Fan Weng, Huan Tian, Zhi‐Yu Qiu, Yin Li, Shi‐Yong Lin, Mei‐Xian Ye, Qing‐Jian Ou, Cheng‐Hua Gong, Zhen‐Hai Lu, Zhi‐Zhong Pan, De‐Sen Wan, Jian‐Hong Peng, Yu‐Jing Fang
Cancer Medicine.2022; 11(22): 4321. CrossRef
Prediction Model for Hypertension and Diabetes Mellitus Using Korean Public Health Examination Data (2002–2017)
Yong Whi Jeong, Yeojin Jung, Hoyeon Jeong, Ji Hye Huh, Ki-Chul Sung, Jeong-Hun Shin, Hyeon Chang Kim, Jang Young Kim, Dae Ryong Kang
Diagnostics.2022; 12(8): 1967. CrossRef
Typ-2-Diabetes mellitus und gastrointestinale Krebsvorsorge
Hans Scherübl
Diabetes aktuell.2022; 20(06): 287. CrossRef
The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature
Chin-Hsiao Tseng
Biomolecules.2021; 11(7): 1022. CrossRef
Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing
Christian von Wagner, Dorina Cadar, Ruth A Hackett, Panayotes Demakakos, Rebecca J Beeken, Stacy Cooper Bailey, Michael Wolf, Andrew Steptoe, Cristina Renzi, Sandro T Stoffel
Journal of Medical Screening.2020; 27(1): 25. CrossRef
Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis
Dominika Bhatia, Iliana C. Lega, Wei Wu, Lorraine L. Lipscombe
Diabetologia.2020; 63(1): 34. CrossRef
Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Iliana C Lega, Lorraine L Lipscombe
Endocrine Reviews.2020; 41(1): 33. CrossRef
The Incidences and Characteristics of Various Cancers in Patients on Dialysis: a Korean Nationwide Study
Soon Kil Kwon, Joung-Ho Han, Hye-Young Kim, Gilwon Kang, Minseok Kang, Yeonkook J. Kim, Jinsoo Min
Journal of Korean Medical Science.2019;[Epub] CrossRef
Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
Sunghwan Suh, Kwang-Won Kim
Diabetes & Metabolism Journal.2019; 43(6): 733. CrossRef

Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries: Eunji Choi, Sangeun Lee, Bui Cam Nhung, Mina Suh, Boyoung Park, Jae Kwan Jun, Kui Son Choi; Epidemiol Health. 2017;39:e2017006. Published online February 5, 2017; DOI: https://doi.org/10.4178/epih.e2017006

24,206 View
464 Download
99 Web of Science
93 Crossref

Abstract PDF

Abstract

OBJECTIVES
Assessing long-term success and efficiency is an essential part of evaluating cancer control programs. The mortality-to-incidence ratio (MIR) can serve as an insightful indicator of cancer management outcomes for individual nations. By calculating MIRs for the top five cancers in Organization for Economic Cooperation and Development (OECD) countries, the current study attempted to characterize the outcomes of national cancer management policies according to the health system ranking of each country.

METHODS

The MIRs for the five most burdensome cancers globally (lung, colorectal, prostate, stomach, and breast) were calculated for all 34 OECD countries using 2012 GLOBOCAN incidence and mortality statistics. Health system rankings reported by the World Health Organization in 2000 were updated with relevant information when possible. A linear regression model was created, using MIRs as the dependent variable and health system rankings as the independent variable.

RESULTS

The linear relationships between MIRs and health system rankings for the five cancers were significant, with coefficients of determination ranging from 49 to 75% when outliers were excluded. A clear outlier, Korea reported lower-than-predicted MIRs for stomach and colorectal cancer, reflecting its strong national cancer control policies, especially cancer screening.

CONCLUSIONS

The MIR was found to be a practical measure for evaluating the long-term success of cancer surveillance and the efficacy of cancer control programs, especially cancer screening. Extending the use of MIRs to evaluate other cancers may also prove useful.

Summary

Citations

Citations to this article as recorded by

Cell death in glioblastoma and the central nervous system
Kyle Malone, Eric LaCasse, Shawn T. Beug
Cellular Oncology.2025; 48(2): 313. CrossRef
Global assessment of leukemia care quality: insights from the quality of care index (QCI) from 1990 to 2021
Yuzhe Pan, Qian Liu, Nan Zhang, Shuang Peng, Xinqi Li, Fuling Zhou
eClinicalMedicine.2025; 79: 102996. CrossRef
Analyzing the cancer mortality-to-incidence ratios and health expenditures in the aging population: a 20-year comparative study across high-income countries
Majed Ramadan, Shadell AlGhamdi, Rawiah Alsiary
Frontiers in Aging.2025;[Epub] CrossRef
Disparities in Cancer Mortality Worldwide: A Novel Metric for Measuring Global Disparities and Prioritizing Cancer Control Efforts
Thomas M. Diehl, Kaleem S. Ahmed, Sheida Pourdashti, Lily Stalter, Jessica Hellner, Ewen M. Harrison, Syed Nabeel Zafar
JCO Global Oncology.2025;[Epub] CrossRef
A comparative analysis of global and Chinese trends in the burden of kidney cancer from 1990 to 2021
Zhongli Qiao, Jun Xiong, Shenyu Zhang, Lin Chen, Jialin Wang, Runze Chen
Scientific Reports.2025;[Epub] CrossRef
Global Cancer Burden in Adolescents and Young Adults Based on Human Development Index and Income Status
Mohammad Arfat Ganiyani, Mounika Addula, Rajiv Doddamani, Adithya Chennamadhavuni, Manas Pustake, Atulya Aman Khosla, Arjun Pon Avudaiappan, Rohan Garje
Journal of Adolescent and Young Adult Oncology.2025; 14(2): 137. CrossRef
Epidemiology, socioeconomic correlates, and trend projections of multiple myeloma in Asia over 2020–2040
Seyed Ehsan Mousavi, Mehran Ilaghi, Sarah Aflatoonian, Seyed Aria Nejadghaderi
Heliyon.2025; 11(9): e43325. CrossRef
Global burden of 34 cancers among women in 2020 and projections to 2040: Population‐based data from 185 countries/territories
Habtamu Mellie Bizuayehu, Abel F. Dadi, Tahir A. Hassen, Daniel Bekele Ketema, Kedir Y. Ahmed, Zemenu Y. Kassa, Erkihun Amsalu, Getiye Dejenu Kibret, Addisu Alehegn Alemu, Animut Alebel, Jemal E. Shifa, Yibeltal Assefa, Gizachew A. Tessema, Peter Sarich,
International Journal of Cancer.2024; 154(8): 1377. CrossRef
Gastric cancer screening in Western countries: A call to action
Fabio Farinati, Filippo Pelizzaro
Digestive and Liver Disease.2024; 56(10): 1653. CrossRef
Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study
Yehoda M Martei, Lebogang Mokokwe, Ngwao Ngwako, Keaobaka Kebuang, Dipho I Setlhako, Goitsemang Gabaatlhole, Bontswanetse Baaitse, Tumisang Segadimo, Lawrence N Shulman, Frances Barg, Babe E Gaolebale
BMJ Open.2024; 14(1): e073867. CrossRef
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis
Jing Yang, Xin Liu, Qiu-Zi Zhong, Yong Yang, Tao Wu, Si-Ye Chen, Bo Chen, Yong-Wen Song, Hui Fang, Shu-Lian Wang, Yue-Ping Liu, Jing Jin, Ning Li, Ning-Ning Lu, Hao Jing, Yuan Tang, Fan Chen, Xi-Mei Zhang, Wenwen Zhang, Yirui Zhai, Shu-Nan Qi, Ye-Xiong Li
Cancer Letters.2024; 595: 216793. CrossRef
Utility of auto fluorescence-guided biopsy in suspected lung cancer patients with bronchial mucosal lesions
Gaozhe Wang, Yan Jin, Kunlong Xiong, Xiaoyan Jin, Linfeng Wang, Chenwei Li
Photodiagnosis and Photodynamic Therapy.2024; 46: 104057. CrossRef
Policy strategies for capacity building and scale up of the workforce for comprehensive cancer care: a systematic review
D. Trapani, S.S. Murthy, N. Hammad, R. Casolino, D.C. Moreira, F. Roitberg, J.-Y. Blay, G. Curigliano, A.M. Ilbawi
ESMO Open.2024; 9(4): 102946. CrossRef
Global, regional, and national burdens of early onset pancreatic cancer in adolescents and adults aged 15–49 years from 1990 to 2019 based on the Global Burden of Disease Study 2019: a cross-sectional study
Zheng Li, Xiaojie Zhang, Chongyuan Sun, Zefeng Li, He Fei, Dongbing Zhao
International Journal of Surgery.2024; 110(4): 1929. CrossRef
Self-Assembly of Peptides as an Alluring Approach toward Cancer Treatment and Imaging
Muhammad Hamza Ghafoor, Ben-Li Song, Lei Zhou, Zeng-Ying Qiao, Hao Wang
ACS Biomaterials Science & Engineering.2024; 10(5): 2841. CrossRef
Cutaneous Melanoma Mortality-to-Incidence Ratio and Its Association With Socioeconomic and Healthcare Factors in Canada: A National Ecological Study
Santina Conte, Michelle Le, Amina Moustaqim-Barrette, Feras M. Ghazawi, Anastasiya Muntyanu, François Lagacé, Akram Alakel, Elham Rahme, Steven J. Glassman, Ivan V. Litvinov
Journal of Cutaneous Medicine and Surgery.2024; 28(5): 439. CrossRef
Estimativa de incidência de câncer no Brasil e regiões em 2018: aspectos metodológicos
Beatriz Cordeiro Jardim, Washington Leite Junger, Regina Paiva Daumas, Gulnar Azevedo e Silva
Cadernos de Saúde Pública.2024;[Epub] CrossRef
Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics
Qianru Li, Changfa Xia, He Li, Xinxin Yan, Fan Yang, Mengdi Cao, Shaoli Zhang, Yi Teng, Siyi He, Maomao Cao, Wanqing Chen
Frontiers of Medicine.2024; 18(5): 911. CrossRef
Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population‐based estimates
Habtamu Mellie Bizuayehu, Abel F. Dadi, Kedir Y. Ahmed, Teketo Kassaw Tegegne, Tahir Ahmed Hassen, Getiye Dejenu Kibret, Daniel Bekele Ketema, Meless G. Bore, Subash Thapa, Daniel Bogale Odo, Zemenu Y. Kassa, Desalegn Markos Shifti, Erkihun Amsalu, Peter
Cancer.2024;[Epub] CrossRef
Global epidemiology of liver cancer 2022: An emphasis on geographic disparities
Qianru Li, Chao Ding, Maomao Cao, Fan Yang, Xinxin Yan, Siyi He, Mengdi Cao, Shaoli Zhang, Yi Teng, Nuopei Tan, Jiachen Wang, Changfa Xia, Wanqing Chen
Chinese Medical Journal.2024; 137(19): 2334. CrossRef
Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from GLOBOCAN 2020
Seyed Ehsan Mousavi, Mehran Ilaghi, Yasaman Mirzazadeh, Alireza Mosavi Jarrahi, Seyed Aria Nejadghaderi
Frontiers in Oncology.2024;[Epub] CrossRef
Synthesis of novel propargylated derivatives of noscapine using A3-coupling reaction and their anticancer properties
Fatemeh Famarini, Peyman Salehi, Bahareh Heidari, Morteza Bararjanian, Atefeh Hajiagha Bozorgi, Afsaneh Tavasoli, Zahra Davarzani
Journal of the Iranian Chemical Society.2024; 21(11): 2841. CrossRef
Cancer profiling in the littoral region of cameroon: Insights from a major health centre
Suares Clovis Oukouomi Noutchie
International Journal of Research in Business and Social Science (2147- 4478).2024; 13(6): 202. CrossRef
Global burden of cancer pattern in 2020 & prediction to 2040 among older adults
Manoj Kalita, Devaraja M., Indranil Saha, Amit Chakrabarti
The Indian Journal of Medical Research.2024; 160: 397. CrossRef
Pediatric and adolescent cancer disparities in the Middle East and North Africa (MENA) region: incidence, mortality, and survival across socioeconomic strata
Ankita Shukla, Rouba Karen Zeidan, Basema Saddik
BMC Public Health.2024;[Epub] CrossRef
Global, regional, and national trends of dementia incidence and risk factors, 1990–2019: A Global Burden of Disease study
Abolfazl Avan, Vladimir Hachinski
Alzheimer's & Dementia.2023; 19(4): 1281. CrossRef
Improved Trends in the Mortality-to-Incidence Ratios for Liver Cancer in Countries with High Development Index and Health Expenditures
Chang-Cheng Su, Brian-Shiian Chen, Hsin-Hung Chen, Wen-Wei Sung, Chi-Chih Wang, Ming-Chang Tsai
Healthcare.2023; 11(2): 159. CrossRef
Updated epidemiology of gastrointestinal cancers in East Asia
Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong
Nature Reviews Gastroenterology & Hepatology.2023; 20(5): 271. CrossRef
Peptide Self-Assembled Nanocarriers for Cancer Drug Delivery
Vijay Bhooshan Kumar, Busra Ozguney, Anastasia Vlachou, Yu Chen, Ehud Gazit, Phanourios Tamamis
The Journal of Physical Chemistry B.2023; 127(9): 1857. CrossRef
Stigma and Social Determinants of Health Associated With Fidelity to Guideline-Concordant Therapy in Patients With Breast Cancer Living With and Without HIV in Botswana
Yehoda M Martei, Modesty Obasohan, Lebogang Mokokwe, Tlotlo Ralefala, Mosepele Mosepele, Robert Gross, Frances K Barg
The Oncologist.2023; 28(12): e1230. CrossRef
Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
Joanne Wing Yan Chiu, Soo Chin Lee, James Chung-man Ho, Yeon Hee Park, Ta-Chung Chao, Sung-Bae Kim, Elgene Lim, Ching-Hung Lin, Sherene Loi, Su Ying Low, Lynette Li San Teo, Winnie Yeo, Rebecca Dent
Drug Safety.2023; 46(10): 927. CrossRef
Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020
Maedeh Amini, Rajesh Sharma, Chinmay Jani
Archives of Public Health.2023;[Epub] CrossRef
Unfavorable cancer mortality‐to‐incidence ratios in patients with schizophrenia: A nationwide cohort study in Taiwan, 2000–2019
Chu‐Syuan Cheng, Wen‐Yin Chen, Hu‐Ming Chang, Chun‐Hung Pan, Sheng‐Siang Su, Shang‐Ying Tsai, Chiao‐Chicy Chen, Chian‐Jue Kuo
Acta Psychiatrica Scandinavica.2023; 148(4): 347. CrossRef
Mortality‐to‐incidence ratio of early‐onset colorectal cancer in high‐income Asian and Middle Eastern countries: A systemic analysis of the Global Burden of Diseases Study 2019
Majed Ramadan, Rawiah A. Alsiary, Doaa A. Aboalola
Cancer Medicine.2023; 12(21): 20604. CrossRef
Spiritual coping strategies: Relationship with physical, anxiety, and depression symptoms of patients with cancer
Atefeh Ahmadi, Aazam Heidarzadeh, Mahlagha Dehghan, Mohammah Hossein Safarizadeh, Mansooreh Azizzadeh Forouzi
Indian Journal of Cancer.2023;[Epub] CrossRef
Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019
Mingjuan Liu, Mengyin Wu, Xintong Liu, Jia Zhou, Yining Lan, Hanlin Zhang, Xinyi zhang, Ling Leng, Heyi Zheng, Jun Li
Archives of Dermatological Research.2023; 315(10): 2893. CrossRef
The fraction of life years lost after diagnosis (FLYLAD): a person-centred measure of cancer burden
David Banham, Jonathan Karnon, Alex Brown, David Roder, John Lynch
Population Health Metrics.2023;[Epub] CrossRef
Global trend analysis of diabetes mellitus incidence, mortality, and mortality-to-incidence ratio from 1990 to 2019
Mohammadreza Balooch Hasankhani, Hossein Mirzaei, Ali Karamoozian
Scientific Reports.2023;[Epub] CrossRef
Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study
Chinmay T. Jani, Alaaeldin Ahmed, Harpreet Singh, Christian Mouchati, Omar Al Omari, Padmanabh S. Bhatt, Rajesh Sharma, Minaam Farooq, Weitao Liu, Joseph Shalhoub, Dominic Marshall, Justin D. Salciccioli, Jeremy L. Warner, Prudence Lam
JCO Global Oncology.2023;[Epub] CrossRef
Type 1 diabetes mellitus disease burden in high health expenditure countries between 1990 and 2019
Michael Edwards, Aurimas Kudzinskas, Andrew Alazawi, Will Hughes, Richard Goodall, Eleanor Harbinson, Justin Salciccioli, Dominic Marshall, Joseph Shalhoub
Diabetes and Vascular Disease Research.2023;[Epub] CrossRef
Spatial and temporal patterns of prostate cancer burden and their association with Socio‐Demographic Index in Asia, 1990–2019
Li‐Sha Luo, Jun‐Feng Jiang, Hang‐Hang Luan, Hao Zi, Cong Zhu, Bing‐Hui Li, Xian‐Tao Zeng
The Prostate.2022; 82(2): 193. CrossRef
Cancer of unknown primary ‐ incidence, mortality trend, and mortality‐to‐incidence ratio is associated with human development index in Central Serbia, 1999–2018: Evidence from the national cancer registry
Aleksandra Ignjatović, Miodrag Stojanović, Zoran Milošević, Marija Anđelković Apostolović, Tamara Filipović, Nataša Rančić, Roberta Marković, Marija Topalović, Dijana Stojanović, Suzana Otašević
European Journal of Cancer Care.2022;[Epub] CrossRef
Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990–2019
Sara Momtazmanesh, Sahar Saeedi Moghaddam, Elaheh Malakan Rad, Sina Azadnajafabad, Narges Ebrahimi, Esmaeil Mohammadi, Mahtab Rouhifard, Negar Rezaei, Masoud Masinaei, Nazila Rezaei, Mohammad Keykhaei, Arya Aminorroaya, Azin Ghamari, Bagher Larijani, Fars
European Journal of Preventive Cardiology.2022; 29(8): 1287. CrossRef
Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study
Maedeh Amini, Mehdi Azizmohammad Looha, Elaheh Zarean, Mohamad Amin Pourhoseingholi
BMC Public Health.2022;[Epub] CrossRef
Mapping Cancer in Africa: A Comprehensive and Comparable Characterization of 34 Cancer Types Using Estimates From GLOBOCAN 2020
Rajesh Sharma, Aashima, Mehak Nanda, Claudio Fronterre, Paul Sewagudde, Anna E. Ssentongo, Kelsey Yenney, Nina D. Arhin, John Oh, Forster Amponsah-Manu, Paddy Ssentongo
Frontiers in Public Health.2022;[Epub] CrossRef
Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs
Freddie Bray, D Maxwell Parkin, Freddy Gnangnon, Gontse Tshisimogo, Jean-Felix Peko, Innocent Adoubi, Mathewos Assefa, Lamin Bojang, Baffour Awuah, Moussa Koulibaly, Nathan Buziba, Anne Korir, Charles Dzamalala, Bakarou Kamate, Shyam Manraj, Josefo Ferro,
The Lancet Oncology.2022; 23(6): 719. CrossRef
Burden of type 1 diabetes mellitus in the North Africa and Middle East Region, 1990–2019; findings from the global burden of disease study
Shahnaz Esmaeili, Sahar Saeedi Moghaddam, Nazli Namazi, Fatemeh Bandarian, Zahra Esfahani, Maryam Peimani, Sarvenaz Shahin, Ensieh Nasli-Esfahani, Isa Akbarzadeh, Ali Ghanbari, Negar Rezaei, Nazila Rezaei, Bagher Larijani, Farshad Farzadfar
Diabetes Research and Clinical Practice.2022; 188: 109912. CrossRef
Cancer incidence and mortality and risk factors in member countries of the " Belt and Road " initiative
Baohua Wang, Fengdie He, Yanan Hu, Qiutong Wang, Dan Wang, Yuting Sha, Jing Wu
BMC Cancer.2022;[Epub] CrossRef
Geographical Differences in Kidney Cancer Outcomes of Patients Treated with Immunotherapy: A Systematic Review
Vinicius Knackfuss Gonçalves, Fernando Sabino Marques Monteiro, Antonia Angeli Gazola, Felipe Pizzolo, Júlia Elisa Hübner, Rodrigo Pellegrini, Alessandra Borba, André P. Fay
Kidney Cancer.2022; 6(2): 129. CrossRef
Global burden of disease study at the world health organization: research methods for the most comprehensive global study of disease and underlying health policies
Lee Smith, Jae Il Shin, Soo Young Hwang, Kalthoum Tizaoui, Elena Dragioti, Louis Jacob, Karel Kostev, Seung Won Lee, Ai Koyanagi
Life Cycle.2022;[Epub] CrossRef
Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990–2019
Mohsen Abbasi-Kangevari, Naser Ahmadi, Nima Fattahi, Negar Rezaei, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Sahar Saeedi Moghaddam, Sina Azadnajafabad, Zahra Esfahani, Ali-Asghar Kolahi, Shahin Roshani, Sahba Rezazadeh-Khadem, Fateme Gorgani, Seyyed
PLOS ONE.2022; 17(8): e0271284. CrossRef
A scoping review on population-centered indicators for cancer care continuum
Vasuki Rajaguru, Jieun Jang, Jeoung A. Kwon, Jae Hyun Kim, Jaeyong Shin, Mison Chun
Frontiers in Public Health.2022;[Epub] CrossRef
COMPARISON OF TEMPORAL TRENDS IN THE GLOBAL BURDEN OF TRACHEA, BRONCHIAL, AND LUNG CANCER
İskender ÇETİNTÜRK, Vahit YİĞİT
Giresun Üniversitesi İktisadi ve İdari Bilimler Dergisi.2022; 8(2): 254. CrossRef
ANALYSIS OF INCIDENCE AND MORTALITY OF GASTROINTESTINAL MALIGNANT TUMORS IN UKRAINE AND WORLDWIDE
Valeriy Zub
Acta Medica Leopoliensia.2022; 28(3-4): 22. CrossRef
Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018
Rajesh Sharma
Breast Cancer Research and Treatment.2021; 187(2): 557. CrossRef
A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017
Mohammad Keykhaei, Masood Masinaei, Esmaeil Mohammadi, Sina Azadnajafabad, Negar Rezaei, Sahar Saeedi Moghaddam, Nazila Rezaei, Maryam Nasserinejad, Mohsen Abbasi-Kangevari, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Rosa Haghshenas, Kamyar Koliji, Far
Experimental Hematology & Oncology.2021;[Epub] CrossRef
The global landscape of drug development of trastuzumab biosimilars
Dario Trapani, Giuseppe Curigliano
Journal of Cancer Policy.2021; 28: 100273. CrossRef
Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
Maedeh Amini, Farid Zayeri, Masoud Salehi
BMC Public Health.2021;[Epub] CrossRef
Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017
Sina Azadnajafabad, Sahar Saeedi Moghaddam, Esmaeil Mohammadi, Negar Rezaei, Erfan Ghasemi, Nima Fattahi, Arya Aminorroaya, Reza Azadnajafabad, Armin Aryannejad, Nazila Rezaei, Shohreh Naderimagham, Vahid Haghpanah, Ali H. Mokdad, Hossein Gharib, Farshad
Cancer Medicine.2021; 10(7): 2496. CrossRef
National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990
Bahar Ataeinia, Sahar Saeedi Moghaddam, Mahsima Shabani, Kimiya Gohari, Ali Sheidaei, Nazila Rezaei, Shohreh Naderimagham, Erfan Ghasemi, Mahtab Rouhifard Khalilabad, Shahin Roshani, Yosef Farzi, Farshad Farzadfar
Frontiers in Oncology.2021;[Epub] CrossRef
Honey and its protein components: Effects in the cancer immunology
Ivan Chan‐Zapata, Maira Rubí Segura‐Campos
Journal of Food Biochemistry.2021;[Epub] CrossRef
A Comparison of the United States and Austrian Healthcare Needs and Systems
Margaret McAlister, Joey D. Helton
INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2021;[Epub] CrossRef
Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high‐ and middle‐income Asian countries
Jasmine Lim, Mizuki Onozawa, Marniza Saad, Teng Aik Ong, Rohan Malek, Hideyuki Akaza
Cancer Science.2021; 112(6): 2071. CrossRef
A spatial assessment of prostate cancer mortality-to-incidence ratios among South Carolina veterans: 1999–2015
Peter Georgantopoulos, Jan M. Eberth, Bo Cai, Gowtham Rao, Charles L. Bennett, Christopher T. Emrich, Kathlyn S. Haddock, James R. Hébert
Annals of Epidemiology.2021; 59: 24. CrossRef
Assessment of quality benchmarks in adenoma detection in Mexico
Nancy E. Aguilar-Olivos, Ricardo Balanzá, Fernando Rojas-Mendoza, Rodrigo Soto-Solis, Mario A. Ballesteros-Amozurrutia, Norma González-Uribe, Justo A. Fernández-Rivero
Endoscopy International Open.2021; 09(06): E796. CrossRef
Favorable Lip and Oral Cancer Mortality-to-Incidence Ratios in Countries with High Human Development Index and Expenditures on Health
Wen-Wei Sung, Yong-Chen Hsu, Chen Dong, Ying-Ching Chen, Yu-Chi Chao, Chih-Jung Chen
International Journal of Environmental Research and Public Health.2021; 18(11): 6012. CrossRef
In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?
Jihae An, Young Joong Kim, Jae Young Seo, Cheol Mog Hwang, Dong Hyun Oh, Mu-Sik Lee, Keum Won Kim
Egyptian Journal of Radiology and Nuclear Medicine.2021;[Epub] CrossRef
Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
Tzu-Wei Yang, Chi-Chih Wang, Wei-Cheng Hung, Yu-Hsiang Liu, Wen-Wei Sung, Ming-Chang Tsai
Frontiers in Public Health.2021;[Epub] CrossRef
Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis
Tlotlo Ralefala, Lebogang Mokokwe, Swetha Jammalamadugu, Dumelang Legobere, Warona S. Motlhwa, Anthony A. Oyekunle, Surbhi Grover, Frances K. Barg, Lawrence N. Shulman, Yehoda M. Martei
The Oncologist.2021; 26(12): e2200. CrossRef
Improving Quality Indicator of Melanoma Management – Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study
Máté Várnai, Zoltán Kiss, Rolland Gyulai, Judit Oláh, Péter Holló, Gabriella Emri, András Csejtei, István Kenessey, Angéla Benedek, Zoltán Polányi, Zsófia Nagy-Erdei, Andrea Dániel, Kata Knollmajer, György Rokszin, Ibolya Fábián, Zsófia Barcza, Csaba Polg
Frontiers in Oncology.2021;[Epub] CrossRef
Cancer survival status among male population of Northeast India
Manoj Kalita, Jagannath Dev Sharma, Debanjana Barman, Nizara Baishya, Chandi Ram Kalita
Annals of Oncology Research and Therapy.2021; 1(1): 28. CrossRef
Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery
Rolvix H. Patterson, Victoria G. Fischman, Isaac Wasserman, Jennifer Siu, Mark G. Shrime, Johannes J. Fagan, Wayne Koch, Blake C. Alkire
Otolaryngology–Head and Neck Surgery.2020; 162(3): 296. CrossRef
Trends of National and Subnational Incidence of Childhood Cancer Groups in Iran: 1990–2016
Mahsima Shabani, Sahar Saeedi Moghaddam, Bahar Ataeinia, Nazila Rezaei, Farnam Mohebi, Bahram Mohajer, Kimiya Gohari, Ali Sheidaei, Farhad Pishgar, Moein Yoosefi, Farzad Kompani, Farshad Farzadfar
Frontiers in Oncology.2020;[Epub] CrossRef
Evaluation of the Cardiac Protection Conferred by Proanthocyanidins in Grape Seeds against Development of Ehrlich Solid Tumors in Mice
Maha Abdulrahman Aldubayan, Sivagnanam Thamilselvan
BioMed Research International.2020;[Epub] CrossRef
The economic burden of cancer care for Syrian refugees: a population-based modelling study
Rima A Abdul-Khalek, Ping Guo, Forbes Sharp, Adrian Gheorghe, Omar Shamieh, Tezer Kutluk, Fouad Fouad, Adam Coutts, Ajay Aggarwal, Deborah Mukherji, Ghassan Abu-Sittah, Kalipso Chalkidou, Richard Sullivan
The Lancet Oncology.2020; 21(5): 637. CrossRef
Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment
Heinz Ludwig, Susie Novis Durie, Angela Meckl, Axel Hinke, Brian Durie
The Oncologist.2020; 25(9): e1406. CrossRef
Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018
Rajesh Sharma
Japanese Journal of Clinical Oncology.2020; 50(12): 1370. CrossRef
Evaluating the Effect of Medicaid Expansion on Black/White Breast Cancer Mortality Disparities: A Difference-in-Difference Analysis
Jason Semprini, Olufunmilayo Olopade
JCO Global Oncology.2020; (6): 1178. CrossRef
State-Level Disparity in Lung Cancer Survival in the United States
Yu-Che Lee, Rafael A. Calderon-Candelario, Gregory E. Holt, Michael A. Campos, Mehdi Mirsaeidi
Frontiers in Oncology.2020;[Epub] CrossRef
Inequalities in the burden of female breast cancer in Brazil, 1990–2017
Maximiliano Ribeiro Guerra, Mário Círio Nogueira, Deborah Carvalho Malta, Camila Soares Lima Côrrea, Maria de Fatima Marinho de Souza, Maria Paula Curado, Mariana Santos Felisbino-Mendes, Meghan Mooney, Mohsen Naghavi, Maria Teresa Bustamante-Teixeira
Population Health Metrics.2020;[Epub] CrossRef
Disparities in mortality‐to‐incidence ratios by race/ethnicity for female breast cancer in New York City, 2002‐2016
Tamar B. Nobel, Charles K. Asumeng, John Jasek, Kellie C. Van Beck, Ruchi Mathur, Baozhen Qiao, Jennifer J. Brown
Cancer Medicine.2020; 9(21): 8226. CrossRef
Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles
Lu Yu, Mingyu Xu, Wenwen Xu, Wei Xiao, Xue-hua Jiang, Ling Wang, Huile Gao
Nano Letters.2020; 20(12): 8903. CrossRef
Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application
Girolamo Ranieri, Mariarita Laforgia, Patrizia Nardulli, Simona Ferraiuolo, Pasquale Molinari, Ilaria Marech, Cosmo Damiano Gadaleta
Cancers.2019; 11(2): 141. CrossRef
Melanoma prognosis in the United States: Identifying barriers for improved care
Zachary H. Hopkins, Christopher Moreno, Ryan Carlisle, Aaron M. Secrest
Journal of the American Academy of Dermatology.2019; 80(5): 1256. CrossRef
The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
Erik Ladomersky, Denise M. Scholtens, Masha Kocherginsky, Elizabeth A. Hibler, Elizabeth T. Bartom, Sebastian Otto-Meyer, Lijie Zhai, Kristen L. Lauing, Jaehyuk Choi, Jeffrey A. Sosman, Jennifer D. Wu, Bin Zhang, Rimas V. Lukas, Derek A. Wainwright
Frontiers in Pharmacology.2019;[Epub] CrossRef
The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival
Libby Ellis, Aurélien Belot, Bernard Rachet, Michel P. Coleman
Journal of Global Oncology.2019; (5): 1. CrossRef
National Cancer Mortality-to-Incidence Ratio (MIR) in Iran (2005 - 2014)
Atieh Akbari, Maryam Khayamzadeh, Reza Salmanian, Ali Ghanbari Motlagh, Gholamreza Roshandel, Maryam Nouri, Mohammad Esmaeil Akbari
International Journal of Cancer Management.2019;[Epub] CrossRef
The Association between Mortality-to-Incidence Ratios and Health Expenditures in Brain and Nervous System Cancers
Tsung-Han Lee, Wen-Wei Sung, Lung Chan, Hsiang-Lin Lee, Sung-Lang Chen, Yu-Hui Huang, Aij-Lie Kwan
International Journal of Environmental Research and Public Health.2019; 16(15): 2739. CrossRef
miR‐181a/b therapy in lung cancer: reality or myth?
Cornelia Braicu, Diana Gulei, Roxana Cojocneanu, Lajos Raduly, Ancuta Jurj, Erik Knutsen, George Adrian Calin, Ioana Berindan‐Neagoe
Molecular Oncology.2019; 13(1): 9. CrossRef
Breast Cancer: Reimbursement Policies and Adoption of New Therapeutic Agents by National Health Systems
Dario Trapani, Giuseppe Curigliano, Alexandru Eniu
Breast Care.2019; 14(6): 373. CrossRef
Epidemiology of prostate cancer in Asian countries
Takahiro Kimura, Shin Egawa
International Journal of Urology.2018; 25(6): 524. CrossRef
Cause-of-death statistics in 2016 in the Republic of Korea
Hyun-Young Shin, Ji-Youn Lee, Jee-Eun Kim, Seokmin Lee, Heejo Youn, Heyran Kim, Jeonghun Lee, Min Sim Park, Sun Huh
Journal of the Korean Medical Association.2018; 61(9): 573. CrossRef
Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries
Hsiang-Lin Lee, Cheng-Ming Peng, Cheng-Yu Huang, Shin-Yi Wu, Ming-Chang Tsai, Chi-Chih Wang, Sung-Lang Chen, Chun-Che Lin, Chien-Ning Huang, Wen-Wei Sung
BMJ Open.2018; 8(7): e020618. CrossRef

Reliability of Quadruplicated Serological Parameters in the Korean Genome and Epidemiology Study: Jae Jeong Yang, Ji Hyun Yang, Jimin Kim, Lisa Y. Cho, Boyoung Park, Seung Hyun Ma, Sang Hoon Song, Won-Ki Min, Sung Soo Kim, Man Suck Park, Sue K. Park; Epidemiol Health. 2011;33:e2011004. Published online May 19, 2011; DOI: https://doi.org/10.4178/epih/e2011004

19,334 View
107 Download
10 Crossref

Abstract PDF

Abstract

<sec><title>OBJECTIVES</title>The aim of this study was to evaluate whether clinical test values from different laboratories in the Korean Genome and Epidemiology Study (KoGES) can be integrated through a statistical adjustment algorithm with appropriate intra- and inter-laboratory reliability.</sec><sec><title>METHODS</title>External quality control data were obtained from the Korean Society for Laboratory Medicine and quadruplicated standardized serological samples (N=3,200) were manufactured in order to check the intra- and inter-laboratory reliability for aspartic acid transaminase (AST), alanine transaminase (ALT), gamma-glutamyl transpeptidase (γ-GTP), blood urea nitrogen (BUN), creatinine, uric acid (UA), fasting blood sugar (FBS), cholesterol, and triglyceride (TG). As an index of inter- and intra-rater reliability, Pearson's correlation coefficient, intraclass correlation coefficients and kappa statistics were estimated. In addition, to detect the potential for data integration, we constructed statistical compensation models using linear regression analysis with residual analysis, and presented the R-square values.</sec><sec><title>RESULTS</title>All correlation coefficient values indicated good intra- and inter-laboratory reliability, which ranged from 0.842 to 1.000. Kappa coefficients were greater than 0.75 (0.75-1.00). All of the regression models based on the trial results had strong R-square values and zero sums of residuals. These results were consistent in the regression models using external quality control data.</sec><sec><title>CONCLUSION</title>The two laboratories in the KoGES have good intra- and inter-laboratory reliability for ten chemical test values, and data can be integrated through algorithmic statistical adjustment using regression equations.</sec>

Summary

Citations

Citations to this article as recorded by

METS-IR and all-cause mortality in Korean over 60 years old: Korean genome and epidemiology study-health examinees (KoGES-HEXA) cohorts
Ha Eun Ryu, Dong Hyuk Jung, Seok-Jae Heo, Byoungjin Park, Yong Jae Lee
Frontiers in Endocrinology.2024;[Epub] CrossRef
Healthful Plant-Based Diet and Incidence of Type 2 Diabetes in Asian Population
Jihye Kim, Edward Giovannucci
Nutrients.2022; 14(15): 3078. CrossRef
Urinary Sodium-to-Potassium Ratio and Incident Chronic Kidney Disease
Young Su Joo, Hyung Woo Kim, Jong Hyun Jhee, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Jung Tak Park
Mayo Clinic Proceedings.2022; 97(12): 2259. CrossRef
Association between Different Types of Plant-Based Diets and Risk of Dyslipidemia: A Prospective Cohort Study
Kyueun Lee, Hyunju Kim, Casey M. Rebholz, Jihye Kim
Nutrients.2021; 13(1): 220. CrossRef
Dietary Micronutrients and Risk of Chronic Kidney Disease: A Cohort Study with 12 Year Follow-Up
Juyeon Lee, Kook-Hwan Oh, Sue-Kyung Park
Nutrients.2021; 13(5): 1517. CrossRef
Association between Unhealthful Plant-Based Diets and Possible Risk of Dyslipidemia
Sujin Song, Kyueun Lee, Soim Park, Nara Shin, Hyunju Kim, Jihye Kim
Nutrients.2021; 13(12): 4334. CrossRef
Secondhand Smoke and CKD
Jong Hyun Jhee, Young Su Joo, Youn Kyung Kee, Su-Young Jung, Seohyun Park, Chang-Yun Yoon, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Jung Tak Park
Clinical Journal of the American Society of Nephrology.2019; 14(4): 515. CrossRef
Association between Dietary Mineral Intake and Chronic Kidney Disease: The Health Examinees (HEXA) Study
Jeewoo Kim, Juyeon Lee, Kyoung-Nam Kim, Kook-Hwan Oh, Curie Ahn, Jongkoo Lee, Daehee Kang, Sue K. Park
International Journal of Environmental Research and Public Health.2018; 15(6): 1070. CrossRef
Upper Normal Serum Creatinine Concentrations as a Predictor for Chronic Kidney Disease: Analysis of 14 Years’ Korean Genome and Epidemiology Study (KoGES)
Jong Hyun Jhee, Seun Deuk Hwang, Joon Ho Song, Seoung Woo Lee
Journal of Clinical Medicine.2018; 7(11): 463. CrossRef
Dairy Product Intake Is Inversely Associated with Metabolic Syndrome in Korean Adults: Anseong and Ansan Cohort of the Korean Genome and Epidemiology Study
Hyehyung Shin, Yeong Sook Yoon, Yoonna Lee, Cho-il Kim, Sang Woo Oh
Journal of Korean Medical Science.2013; 28(10): 1482. CrossRef

First
Prev
Page of 1
Next
Last

Search